ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

September 11, 1998

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996

Two Studies Suggest Positive HPV Status Can Indicate Improved Patient Outcomes

February 28, 2014